Skip to content
ManitobaBill 240First Reading

Bill 240: The Pharmaceutical Amendment Act

Sponsor: Mrs. CookIntroduced October 14, 2026Checked October 15, 2026
Read the official textOfficial version — Legislative Assembly of Manitoba

Latest development

Received first reading on .

Next: Second Reading debate

What this bill does

This Manitoba bill allows licensed pharmacists to prescribe drugs for a list of minor conditions (such as pink eye, strep throat, yeast infections, and seasonal allergies), subject to regulations that will specify which drugs are permitted and any restrictions on prescribing.

Plain-language summary by Legisail — not legal advice.

Business impact

Compliance
This bill directly affects pharmacists and pharmacy owners operating in Manitoba. Day-to-day pharmacy work will expand to include clinical assessment and prescription writing for about 26 minor conditions — things like treating a customer's cold sore, writing a prescription for a yeast infection, or managing a patient's seasonal allergies without them needing a doctor's visit. Independent pharmacies and small pharmacy teams will need to ensure their staff are trained and compliant with the new regulatory requirements before they start prescribing. Larger pharmacy chains will likely need to update internal protocols, documentation practices, and possibly liability coverage to reflect the expanded scope of practice.

Does this apply to you?

Your own business or clients you watch for — tell Legisail what matters and it checks every bill and regulation against it.

Check for free

Where this bill is

First ReadingOctober 14, 2026
Next: Second Reading debate

Legisail watches this for you

Tell Legisail about your business and it checks every new bill and regulation against it — you only hear about the ones that matter.

Create a free accountFree · 30 seconds · No credit card

At a glance

Bill number
240
Type
Private Member's Public
Jurisdiction
Manitoba
Session
43-3
Takes effect
Not yet known
Official record